A reassessment of the antiphospholipid syndrome.
Harris
E N
EN
Department of Medicine, University of Louisville, KY 40292.
D000906:Antibodies / Q000276:immunology*; D001779:Blood Coagulation Factors / Q000276:immunology; D002308:Cardiolipins / Q000276:immunology; D004194:Disease; D005260:Female; D005313:Fetal Death / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D015994:Incidence; D016682:Lupus Coagulation Inhibitor; D008180:Lupus Erythematosus, Systemic / Q000453:epidemiology / Q000473:pathology; D010743:Phospholipids / Q000276:immunology*; D011247:Pregnancy; D013577:Syndrome; D013927:Thrombosis / Q000453:epidemiology / Q000473:pathology
D000906:Antibodies; D001779:Blood Coagulation Factors; D002308:Cardiolipins; D016682:Lupus Coagulation Inhibitor; D010743:Phospholipids